Summary of "Clinical approach to patient with ascites"

This lecture presents a comprehensive clinical approach to evaluating a patient with ascites, illustrated through a detailed case study of a 50-year-old male with chronic liver disease secondary to Hepatitis C virus (HCV) infection. The discussion emphasizes the importance of systematic history taking, clinical examination, laboratory investigations, imaging, and Ascitic fluid analysis to reach a differential and clinical diagnosis.

Main Ideas and Concepts

Clinical Approach Framework:
- Focus on key points in:
  - History taking
  - Clinical examination
  - Laboratory investigations
  - Imaging studies
  - Ascitic fluid analysis
- These steps guide toward differential diagnosis and management.
Case Presentation:
- 50-year-old male with vague abdominal pain, low-grade fever, chronic liver disease due to HCV.
- Signs: jaundice, spider nevi, splenomegaly, moderate ascites.
- Labs: elevated AST > ALT, hyperbilirubinemia (mainly direct), low albumin, prolonged INR.
- Ultrasound: nodular liver, coarse echotexture, focal hepatic lesion, splenomegaly, ascites.
- Ascitic fluid albumin: 1.6 g/dL; Serum Ascitic Albumin Gradient (SAAG) = 0.8.
History Taking and Clinical Examination:
- Important to clarify:
  - Characteristics and causes of abdominal pain in chronic liver disease.
  - Symptoms/signs of infection (fever, chills, urinary symptoms, respiratory symptoms).
  - History of liver disease etiology (HCV treatment status, other viral hepatitis, alcohol, autoimmune).
  - Symptoms of complications: jaundice, bleeding, encephalopathy, edema.
- Physical exam to detect:
  - Chronic liver disease stigmata (fetor hepaticus, palmar erythema, gynecomastia, tremors, edema).
  - Abdominal signs: liver size, consistency, tenderness; spleen size and features; abdominal collaterals.
Interpretation of Laboratory Data:
- AST/ALT ratio >1 suggests cirrhosis.
- Elevated direct bilirubin and alkaline phosphatase indicate intrahepatic cholestasis.
- Low albumin and high INR reflect impaired synthetic liver function.
- SAAG <1.1 suggests non-portal hypertensive causes of ascites.
- Additional labs needed:
  - Viral load (HCV RNA), hepatitis B markers.
  - Autoimmune markers if indicated.
  - Complete blood count to evaluate anemia, leukocytosis, thrombocytopenia.
  - Renal function tests (urea, creatinine) to assess hepatorenal syndrome.
  - Alpha-fetoprotein for Hepatocellular carcinoma (HCC) screening.
Ascitic fluid analysis:
- Essential for all moderate/severe ascites.
- Tests include:
  - Albumin level (to calculate SAAG).
  - Polymorphonuclear leukocyte count (>250 cells/mm³ diagnostic for spontaneous bacterial peritonitis [SBP]).
  - Culture and sensitivity.
  - Acid-fast bacilli staining (to exclude tuberculosis).
  - Cytology for malignant cells.
Serum Ascitic Albumin Gradient (SAAG):
- SAAG ≥ 1.1 g/dL indicates ascites due to portal hypertension (e.g., cirrhosis).
- SAAG < 1.1 g/dL suggests other causes (infection, malignancy, pancreatic ascites).
- High sensitivity and specificity but not 100% accurate.
Differential Diagnosis of Ascites:
- Portal hypertensive ascites:
  - Liver cirrhosis (most common)
  - Budd-Chiari syndrome (hepatic vein obstruction)
  - Portal vein thrombosis
  - Cardiac causes (right heart failure, constrictive pericarditis)
- Non-portal hypertensive ascites:
  - Infections (SBP, tuberculosis, fungal)
  - Malignancy (primary peritoneal tumors, metastases, HCC)
  - Pancreatic disease (pancreatic ascites)
  - Endocrine, nephrotic syndrome, malnutrition, others
Focal Hepatic Lesions in Cirrhosis:
- Most common cause: Hepatocellular carcinoma (HCC).
- Other benign lesions: hemangioma, adenoma, focal nodular hyperplasia.
- Other malignancies: cholangiocarcinoma, metastases, lymphoma.
- Diagnosis primarily by Triphasic spiral CT or MRI:
  - HCC is a hypervascular tumor with characteristic arterial phase enhancement and rapid washout in portal venous/delayed phases.
  - Biopsy reserved for inconclusive imaging.